KYNB 8-K 2026-10-06

KYNTRA BIO, INC. (KYNB) 8-K dated 2026-10-06 — accession 0001193125-26-415545.

KYNTRA BIO, INC. (KYNB) common stock.

KYNTRA BIO, INC. filed a 8-K on 2026-10-06. Accession 0001193125-26-415545.

This 8-K covers: Listing notice (Item 3.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported KYNB revenue for 2025-12-31 was $6.4M. Net income was $183.5M. Revenue was down 95.6% from 2023-12-31 to 2025-12-31.

Not investment advice. The KYNB SEC hub lists recent forms. The stock page is the research view.